US Patent 11078167 Process for the preparation of Deferasirox
Patent 11078167 was granted and assigned to Aurobindo Pharma on August, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+300 characters)
Article
Patent abstract
The present invention provides an improved process for the preparation of Deferasirox of Formula-I substantially free from ‘hydrazino impurity’ by the condensation of 2-(2-hydrophenyl)-4H-1,3-benzoxazin-4-one of Formula-IV with 4-hydrazino benzoic acid of Formula-V in a polar solvent.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Hero Velladurai0
Janardhana Rao Vascuri0
Ravi Shankar Sathu0
Sivakumaran Meenakshisunderam0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110781670
Date of Patent
August 3, 2021
0Patent Application Number
201807020
Date Filed
July 2, 2018
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 8 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11078167 Process for the preparation of Deferasirox
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11078167
Date of patent
August 3, 2021
Patent application number
20180702
Date Filed
July 2, 2018
Find more entities like US Patent 11078167 Process for the preparation of Deferasirox
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.